The National Advisory Committee on Immunizations has changed its guidelines on mixing and matching the different types of vaccine available to Canadians. Researchers at Dalhousie University have done a pilot study on the efficacy of using an mRNA vaccine for people who first had the viral vector vaccine, AstraZeneca. Doctor Chris Robinson describes how jellyfish helped in their study and why mixing the two types could give the best of both worlds.
